QuickMIC®
Meet the QuickMIC system

Discover how our unique gradient technology provides MIC results in record time.
Learn
About
Get to know Gradientech

Navigate to learn more about our company, our team, and our mission.
Investors
Investor relations

Find our latest press releases, financial reports and information on operations.
Contact
Get in contact with us!

Connect with us for inquiries, collaborations, or any questions you may have.

Investor relations

Latest press release

2026-05-06

Multicenter study shows QuickMIC delivers actionable AST results within the same shift

All press releases

Latest financial report

2026-05-13

Gradientech Interim report Q1 2026

All reports

Upcoming event

All events

Annual report 2025

Here you can read about significant events during the year, our target market and the strategy going forward.

To the annual report

AGM 2026

The Annual General Meeting was held on 18 May 2026. In this section you will find all information from the AGM.

To general meetings

Keep up to date - subscribe

About Gradientech

Gradientech is leading the field of ultra-rapid antibiotic susceptibility testing. We develop next-generation diagnostics that provide patients with the right dose of the right medicine at the right time.